This article is written for readers who want to better understand how prescribed hormonal contraception – particularly oral contraceptive therapy – may influence hair shedding, nutrient status and hormone balance in some susceptible women.
In clinical practice, pathology testing in younger female patients with diffuse scalp hair thinning may sometimes show elevated copper, sex hormone-binding globulin (SHBG) and – when tested – Insulin, reverse T3 (rT3), Cortisol (or cortisol-binding globulin).
These findings may occur alongside low iron stores, zinc deficiency, vitamin B12 deficiency or other nutrient abnormalities.
The key question for the reader is whether these changes are merely coincidental, or whether prescribed synthetic hormone therapy may be a contributing factor in a wider nutrient-hormone disturbance that affects scalp hair density.
The observations discussed here should be understood as educational information and clinical pattern recognition, not as a diagnosis or a directive to stop prescribed medication.
Any change to contraception, hormone therapy, supplementation or treatment should be discussed with your prescribing health practitioner.
A common factor in many of these cases is the use of prescribed synthetic hormone medication – most often the oral contraceptive pill. Similar patterns may also be observed in some women using synthetic hormone replacement therapy (HRT) – although individual responses vary.
Oral contraception was introduced more than 50 years ago and proclaimed a cornerstone of ‘sexual liberation’ for women.
In many ways it has allowed greater physical, sexual and ‘choice’ freedom for females of child-bearing age – as well as an aid in stabilising hormonal conditions such as Endometriosis and Poly-metabolic- ovarian-syndrome (PMOS aka: PCOS).
However, hormonal therapies can also be associated with adverse effects. Some risks are well recognised, while others may be subtler and may contribute to internal changes that affect hair cycling, nutrient availability and general wellbeing in susceptible individuals.
Pathology reports may note that serum or plasma copper can rise in women taking oral hormone medication, and that SHBG is often increased during administration of synthetic oestrogens.
These comments are clinically relevant because they may point to wider downstream effects on mineral balance, thyroid hormone activity and available sex hormones.
These apparently innocuous statements give no hint as to what the consequences are in continuously elevating Copper and/or SHBG on other vital minerals, vitamins and hormonal balance for the woman’s body.
Copper, SHBG and Reverse t3: a cascading interaction:
In a proportion of women using oral contraceptive therapy, SHBG and copper may remain elevated over time. In some cases Reverse t3 may also rise. The proposed clinical concern is that these changes may interact with thyroid function, sex hormone availability and nutrient status in ways that affect hair growth and general wellbeing.
One proposed mechanism is that synthetic oestrogen exposure may contribute to increased copper retention and increased SHBG production in susceptible women.
Higher copper may then further influence oestrogen behavior and nutrient balance – creating a self-reinforcing pattern in some patients.
When copper becomes dominant relative to zinc, it may interfere with the absorption, utilisation or balance of other nutrients, including zinc, iron, vitamin B12, vitamin C and selected trace elements. These nutrients are important for energy, immune function, thyroid activity and healthy hair cycling.
Oestrogen dominance may also lead to hormone imbalance relative to Progesterone (P4) and Testosterone (TT). Excessive Oestrogen is also a common reason for fluid retention in women.
For the reader the practical implication is that hair loss may not be caused by one isolated factor. It may reflect a broader disturbance involving nutrient stores, thyroid hormone activity, stress hormones and sex hormone availability.
What Is Sex Hormone-Binding Globulin?
Sex hormone-binding globulin (SHBG) is a carrier protein produced mainly in the liver. It binds t4 thyroid hormone and a significant proportion of circulating testosterone and oestrogen.
When SHBG is high the amount of free, biologically available hormone may be reduced, which can contribute to symptoms that resemble low androgen or low oestrogen availability.
SHBG may also interact indirectly with thyroid hormone transport and availability. For this reason, persistently elevated SHBG should be interpreted in context rather than viewed as an isolated laboratory result.
Other causes for elevated SHBG are:
- The taking of (synthetic) oestrogen found in hormone therapy.
- Pregnancy
- Hyperthyroidism
- Cirrhosis of the liver
- Medication such as Phenytoin Sodium (Dilantin) that induce hepatic enzyme induction
Factors that decrease SHBG:
- Male hormone (termed ‘Androgens’)
- Progesterone (P4) – low P4 is a common concern for peri-menopausal or menopausal women.
- Cortisol (the stress + anti-inflammatory hormone from our Adrenal Glands)
- High Protein and (good) dietary Fats.
Copper Balance and Nutrient Availability:
Copper is an essential trace mineral but needs to remain in balance with zinc and other nutrients. When copper is high relative to zinc, it may behave as an antagonistic nutrient and restrict the absorption or utilisation of zinc, iron, magnesium, selected B vitamins, vitamins C and E, and certain trace elements.
Copper imbalance may also affect thyroid function. Elevated copper has been proposed to interfere with thyroid hormone receptor activity, while low copper may impair thyroid hormone production. This is why copper should be assessed as part of a broader pattern rather than corrected in isolation.
Other issues with Copper imbalance:
A deficiency of copper can also hinder the deployment of iron by the red blood cells, resulting in the iron being accumulated (but unavailable) within the organs of the body. Because this stored iron cannot be utilised whilst the copper deficiency persists, symptoms of iron deficiency may present – despite an actual iron sufficiency (Watts: 1995).
A refractory low-range or copper deficiency (with an associated Zinc dominance) may also result from Vitamin D deficiency (low Copper + Vitamin D tend to occur together).
If testing reveals BOTH zinc and copper to be deficient – this usually indicates a malabsorption issue in the Gut. Zinc and copper directly compete for absorption at the gut interface, so if one is elevated the other is habitually low or deficient.
Reverse T3 and Hair Cycling:
Reverse T3 is an inactive form of thyroid hormone. It can rise during periods of physiological stress, illness, inflammation, elevated copper or elevated cortisol, nutrient imbalance or an impaired thyroid hormone conversion process.
When reverse T3 is elevated, the body may show underactive-thyroid-like symptoms even when other thyroid markers appear less clearly abnormal.
Clinically, elevated reverse T3 is relevant because active T3 has a crucial influence on hair follicle function. If T3 activity is reduced or blocked, the hair cycle may shift toward increased shedding, reduced density and slower recovery.
For readers experiencing hair thinning, reverse T3 should be considered only as one part of a wider clinical picture. Iron stores, zinc status, vitamin B12, vitamin D, thyroid markers, stress load, recent illness, medication changes and the timing of hair shedding all need to be considered together.
When thyroid hormone activity is impaired, common symptoms may include tiredness, diffuse scalp hair thinning, changes in weight, low mood, dry hair texture and slower recovery from physiological stress.
These symptoms are certainly not specific to reverse T3 alone and should only be interpreted by an experienced practitioner. See article: https://hairlossclinic.com.au/thyroid-process-complexity-at-the-cellular-level/
Clinical Considerations for Readers:
If hormonal contraception or HRT is suspected as an underlying contributor to hair shedding or nutrient disturbance, the cautious approach is to review symptoms, timing, medication history and pathology results with a qualified health practitioner.
Useful discussion points with a practitioner may include:
- Whether the timing of hair shedding corresponds with starting, changing or stopping hormonal therapy.
- Whether pathology testing should include iron studies, zinc, copper, vitamin B12, vitamin D, thyroid markers and – where clinically appropriate – SHBG and reverse T3.
- Whether an alternative contraceptive method may be suitable, based on individual health history, contraceptive needs and risk profile.
- Whether supplementation is indicated – and if so – which nutrients, doses and monitoring schedules are appropriate.
- Monitor hair recovery, energy, sleep, mood and pathology changes over time.
Anticipated Recovery Pattern:
Hair recovery is usually gradual; if the underlying trigger/s are corrected and nutrient status improves, readers may first notice better energy, sleep, mood and concentration before visible hair density improves.
- The first sign of recovery may be improved wellbeing, including better energy, sleep and concentration.
- Hair shedding may then begin to settle, and hair quality or lustre may gradually improve.
- Visible regrowth commonly takes several months – and in some cases where autoimmunity is also an issue – up to twelve months depending on whether other factors or conditions are involved.
It is also important to interpret elevated copper, SHBG or ferritin differently during pregnancy, where complex physiological changes can alter pathology results.
Pregnancy-related hair changes require separate clinical assessment.
Note:
Individual responses to hormonal contraception, HRT, implanted contraceptives and intrauterine devices vary. The patterns described in this article are more likely to be relevant in susceptible women and should not be assumed to apply to everyone.
Telogen effluvium is usually a non-scarring, self-correcting form of diffuse hair shedding once the trigger is removed or corrected.
Even so, it can be highly distressing and should be managed with reassurance, investigation of contributing factors and realistic timelines for recovery.
Conclusion:
Hormonal contraception can be an appropriate and valuable therapy for many women. In some susceptible individuals, however, it may contribute to changes in SHBG, copper balance, nutrient status, thyroid hormone activity and scalp hair follicle cycling.
The most useful approach is not to focus on one marker in isolation, but to assess the full clinical pattern and make any treatment decisions with professional guidance.
For readers experiencing persistent hair shedding, the priority is a careful review of timing, symptoms, medication history, nutritional status and thyroid-related markers.
With the right assessment and support, many cases of diffuse shedding can stabilise and gradually recover.
This article is educational only and is not a substitute for personalised medical advice, diagnosis or treatment.
Copyright Anthony Pearce 2014 (Fully revised July 2026)